glp-1 obesity drugs news today 2025 drug A nice article in The Hindu today highlights the obesity drug news today glp-1

In bariatric surgery, an association of depression with peripheral inflammation was observed regardless of obesity ( The new challenge of GLP-1 RA use reinforces that only an integrative approach is justified in treating each individual patient

For now, it seems that by not choosing and by reducing their innovation efforts, many are risking being in neither.

For clients managing type 2 diabetes, improvements in blood sugar levels can be seen within the first week or two

doi:10.2337/dc10-1393 351

What we do know is that many people regain weight quickly after stopping them, which suggests this may become a lifelong medication for many users, he said

In a meta-analysis of 60 studies involving 60,077 T2D patients, GLP-1RAs marginally reduced the UACR in comparison to placebo and other antidiabetic agents, but resulted in no clinically relevant changes in eGFR ( Renoprotective Mechanisms of GLP-1RAs Experimental studies to elucidate the beneficial effects on DKD have been extensively reported